IODINE (124I) GIRENTUXIMAB Uses, Dosage, Side Effects and more
IODINE (124I) GIRENTUXIMAB is under investigation in clinical trial NCT01762592 (REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT).
Trade Name | IODINE (124I) GIRENTUXIMAB |
Generic | Girentuximab I-124 |
Girentuximab I-124 Other Names | IODINE (124I) GIRENTUXIMAB |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |